| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |